欣大健康投資控股股份有限公司 2025 Sustainability Report

Report summary

• This page summarizes the 2025 sustainability report and ESG report PDF source for 欣大健康投資控股股份有限公司 (4198).
• The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
• third-party verification or assurance body information is not currently provided; this can be used to review report verification, assurance, and disclosure standards.
• Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company

欣大健康投資控股股份有限公司（4198）

Reporting Year

2025

Disclosure Period

2025/01/01 to 2025/12/31

Industry

生技醫療業

Third-party information

third-party verification or assurance body information is not currently provided

PDF source

The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)

9.4

Reporting Boundary：已完成母公司,子公司瑞亞生醫股份有限公司及致瑩生技股份有限公司

Verification：否

Scope 2 Emissions (Tons CO2e)

43

Reporting Boundary：已完成母公司,子公司瑞亞生醫股份有限公司及致瑩生技股份有限公司

Verification：否

Scope 3 Emissions (Tons CO2e)

59

Reporting Boundary：欣大健康投資控股股份有限公司及子公司瑞亞生醫股份有限公司及致瑩生技股份有限公司

Verification：否

Energy Management

Renewable Energy Share

Not disclosed

Reporting Boundary：Not disclosed

Verification：Not disclosed

Water Management

Water Use (Metric Tons)

Not disclosed

Reporting Boundary：Not disclosed

Verification：Not disclosed

Board of Directors

Board Seats (Including Independent Directors)

7

Independent Director Seats

3

Female Director Ratio

12.5%

Ranked 73 among 96 companies in the same industry (percentile 19).

Board Meeting Attendance Rate

95%

Ranked 64 among 96 companies in the same industry (percentile 33).

Independent Director Ratio

42.9%

Ranked 40 among 96 companies in the same industry (percentile 40).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

• Compare how 欣大健康投資控股股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
• Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
• Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.